OTC Markets OTCPK - Delayed Quote USD
BioForce Nanosciences Holdings, Inc. (BFNH)
0.5000
-0.0500
(-9.09%)
At close: May 23 at 3:09:16 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Steven Gagnon | Co-Chief Executive Officer | -- | -- | 1962 |
Mr. John LaViolette | Co-Chief Executive Officer | -- | -- | 1962 |
Mr. Aleksandr Shapiro | President | -- | -- | 1963 |
Mr. Richard Kaiser | CFO, Corporate Secretary, Corporate Governance Officer, Principal Accounting Officer & Director | -- | -- | 1966 |
BioForce Nanosciences Holdings, Inc.
2020 General Booth Boulevard
Suite 230
Virginia Beach, VA 23454
United States
- Sector:
- Consumer Defensive
- Industry: Packaged Foods
- Full Time Employees:
- 3
Description
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It also sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels. BioForce Nanosciences Holdings, Inc. is based in Virginia Beach, Virginia.
Corporate Governance
BioForce Nanosciences Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
August 5, 2025 at 10:59 AM UTC - August 11, 2025 at 12:00 PM UTC
BioForce Nanosciences Holdings, Inc. Earnings Date